EMERGENCY CONTRACEPTION:

    A second chance to prevent pregnancy

    ANTICONCEPCIÓN DE URGENCIA:

    Una segunda oportunidad para prevenir el embarazo

    Contraception d’urgence:

    Une seconde chance de prévenir une grossesse

    Contraccezione d’emergenza:

    Una seconda opportunità per prevenire la gravidanza

Welcome to the European Consortium for Emergency Contraception (ECEC)

Founded in 2012, ECEC works to expand knowledge about and access to Emergency Contraception (EC) in Europe, and promotes the standardization of EC service delivery to ensure equitable access across the region. Since 2020, ECEC also works globally to advance access to EC.

EC is the only contraceptive method that can be used after sex, and it provides women with an additional opportunity to prevent a pregnancy.

Through this website, we hope to contribute to generating and sharing knowledge of EC in Europe and globally. Your contributions are essential to helping us achieve this goal, and we encourage you to share EC information about your country by writing to us at ecec [at] eeirh [dot] org.

Go directly to country-by-country information on EC access

More info
The Ec method

Go directly to the online EC counseling tool (The EC wheel)

Latest News

USA: Illinois expands pharmacy access to emergency contraception through new standing order

By Cristina Puig
Posted in
July 2026. The Illinois Department of Public Health has issued a new standing order to improve access to reproductive health products through community pharmacies. The Standing Order for Reproductive Health: Contraception, Emergency Contraception and Pregnancy Tests, issued on 24 June 2026, is part of broader efforts to expand timely access to contraception by enabling pharmacists…

Taiwan, inspired by Japan, reviews access to emergency contraceptive pills

By Cristina Puig
Posted in
July 2026. Emergency contraceptive pills (ECPs) containing levonorgestrel (LNG) and ulipristal acetate (UPA) are currently prescription products in Taiwan. Last June, the Taiwan Food and Drug Administration (TFDA) proposed adding three prescription medicines—LNG and UPA ECPs, and also misoprostol—to its drug traceability system, with the stated aim of strengthening oversight of drug distribution and compliance….
See more news